Literature DB >> 25755460

Portosystemic myelopathy: a rare neurological presentation of portosystemic shunts.

Prasanna K S Rao1, Keyur A Sheth1, Raghunandan Nadig1, Mallikarjun Patil1, Adarsh K Channagiri1.   

Abstract

Portosystemic myelopathy is an unusual complication in patients with chronic liver disease with hepatic encephalopathy and portosystemic shunts. Here we present a case of 35-year-old male patient who presented to us with difficulty in walking and progressive stiffness in both lower limbs for two months. He had undergone splenectomy with distal splenorenal shunt 20 years back. On physical examination, he had spasticity in both lower limbs of grade 3, with minimal pyramidal weakness in lower limbs, brisk knee and ankle jerks. The plantar response was extensor. Upper limb examination was normal. On investigations, he had hypoalbuminemia, hyperbilirubinemia, increased plasma ammonia levels. Contrast enhanced CT scan abdomen revealed dilated splenorenal shunt and MRI spine showed no spinal cord compression. Electromyoneurogram was also normal. Spastic paraparesis due to portosystemic shunts was diagnosed. Liver transplantation can reverse the myelopathy only in earlier stages, hence early and accurate diagnosis is important.

Entities:  

Keywords:  ANA, anti nuclear antibodies; CECT, contrast enhanced CT; CT, computerised tomography; EEG, electoencephalogram; HE, hepatic encephalopathy; HIV, Human immunodeficiency virus; KF, ring Kayser-Fleischer ring; MRI, magnetic resonance imaging; PSM, portosystemic myelopathy; PSS, portosystemic shunts; TIPS, transjugular portosystemic shunt; cirrhosis of liver; portal hypertension; portosystemic myelopathy; portosystemic shunts

Year:  2012        PMID: 25755460      PMCID: PMC3940410          DOI: 10.1016/j.jceh.2012.10.005

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  6 in total

Review 1.  Portosystemic myelopathy: spastic paraparesis after portosystemic shunting.

Authors:  Harold O Conn; Martin Rössle; Lewis Levy; Franz X Glocker
Journal:  Scand J Gastroenterol       Date:  2006-05       Impact factor: 2.423

2.  Portal-systemic myelopathy after transjugular intrahepatic portosystemic shunt creation: report of four cases.

Authors:  M Q Wang; M D Dake; Z P Cui; Z Q Wang; Y A Gao
Journal:  J Vasc Interv Radiol       Date:  2001-07       Impact factor: 3.464

3.  Failure of presumed hepatic myelopathy to improve after liver transplantation.

Authors:  C Counsell; C Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  Myelopathy in hepatic disease and portosystemic venous anastomosis.

Authors:  L A Liversedge; M D Rawson
Journal:  Lancet       Date:  1966-02-05       Impact factor: 79.321

5.  Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt.

Authors:  Ja Eun Koo; Young-Suk Lim; Sun Jeong Myung; Kyung Suk Suh; Kang Mo Kim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Dong Jin Suh
Journal:  Korean J Hepatol       Date:  2008-03

6.  Clinical features of hepatic myelopathy in patients with chronic liver disease.

Authors:  Y H Yin; Z J Ma; Y H Guan; Y D Ren; Z L Zhang
Journal:  Postgrad Med J       Date:  2009-02       Impact factor: 2.401

  6 in total
  1 in total

1.  Liver Transplantation Reverses Hepatic Myelopathy in 2 Children With Hepatitis A Infection.

Authors:  Roshan Koul; Bikrant Bihari Lal; Viniyendra Pamecha; Shiv Sarin; Seema Alam
Journal:  Child Neurol Open       Date:  2021-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.